CAPTRUST Financial Advisors’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,861
Closed -$1.08M 3104
2025
Q4
$1.08M Buy
37,861
+17,815
+89% +$483K ﹤0.01% 1461
2025
Q3
$590K Buy
20,046
+7,904
+65% +$216K ﹤0.01% 1710
2025
Q2
$350K Sell
12,142
-7,692
-39% -$227K ﹤0.01% 1954
2025
Q1
$694K Buy
19,834
+9,546
+93% +$389K ﹤0.01% 1465
2024
Q4
$458K Buy
10,288
+5,071
+97% +$207K ﹤0.01% 1651
2024
Q3
$238K Buy
+5,217
New +$211K ﹤0.01% 2028
2023
Q3
Sell
-3,062
Closed -$254K 2696
2023
Q2
$254K Buy
+3,062
New +$268K ﹤0.01% 2096
2022
Q3
Sell
-1,448
Closed -$141K 3566
2022
Q2
$141K Buy
1,448
+544
+60% +$55.5K ﹤0.01% 1946
2022
Q1
$102K Sell
904
-418
-32% -$44.6K ﹤0.01% 2251
2021
Q4
$178K Buy
1,322
+52
+4% +$7.24K ﹤0.01% 1724
2021
Q3
$179K Buy
1,270
+108
+9% +$14.5K ﹤0.01% 1638
2021
Q2
$149K Buy
1,162
+376
+48% +$44.3K ﹤0.01% 1734
2021
Q1
$101K Buy
786
+535
+213% +$98.8K ﹤0.01% 1945
2020
Q4
$45K Buy
251
+68
+37% +$15.1K ﹤0.01% 1878
2020
Q3
$41K Buy
183
+80
+78% +$17.9K ﹤0.01% 1703
2020
Q2
$23K Buy
+103
New +$16.1K ﹤0.01% 1889

Other funds holding QDEL

CAPTRUST Financial Advisors's QDEL Position: Q1 2026 in Review

CAPTRUST Financial Advisors sold out of QuidelOrtho (QDEL) in Q1 2026, closing a stake of 37,861 shares — an estimated $1.08M sold.

CAPTRUST Financial Advisors first reported a position in QDEL in Q2 2020 and held it in 16 quarters. The position peaked at $1.08M in Q4 2025. 237 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

  • CAPTRUST Financial Advisors reported no remaining QuidelOrtho position as of Q1 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 37,861 QuidelOrtho shares in Q1 2026, an estimated $1.08M.
  • CAPTRUST Financial Advisors first reported a position in QuidelOrtho in Q2 2020 and held it in 16 quarters.
  • CAPTRUST Financial Advisors's QuidelOrtho position peaked at $1.08M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.